Literature DB >> 12403351

Molecular and cellular mechanisms of donor cell-induced tolerance.

James F George1, Leonik Ahumada, Ailing Lu.   

Abstract

The induction of immunologic tolerance to solid organ allografts is a subject of intense investigation because of the morbidity and mortality associated with standard immunosuppressive therapy. One method that is currently in clinical and preclinical testing involves the transient ablation of recipient T cells using polyclonal antithymocyte sera or monoclonal anti-CD4/CD8 antibody treatment, followed by the posttransplant administration of donor bone marrow cells or of donor peripheral lymphoid populations. Recent studies in our laboratory have shown that the molecular and cellular basis of the prolongation of graft survival by donor cell administration depends on the cellular compartment from which the donor cells were derived. We provide here a brief review of these data followed by new data suggesting that the mode of peripheral and central selection is also dependent on the source from which the donor cells were derived.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12403351     DOI: 10.1385/IR:26:1-3:119

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  37 in total

1.  Programmed cell death of T cells signaled by the T cell receptor and the alpha 3 domain of class I MHC.

Authors:  S R Sambhara; R G Miller
Journal:  Science       Date:  1991-06-07       Impact factor: 47.728

Review 2.  Receptor signalling and the regulation of endocytic membrane transport.

Authors:  M N Seaman; C G Burd; S D Emr
Journal:  Curr Opin Cell Biol       Date:  1996-08       Impact factor: 8.382

3.  Use of allogenic, homozygous bone marrow cells for the induction of specific immunologic tolerance in mice treated with antilymphocyte serum.

Authors:  J J Gozzo; M L Wood; A P Monaco
Journal:  Surg Forum       Date:  1970

4.  An essential role for natural killer cells in augmentation of allograft survival mediated by donor spleen cells.

Authors:  D R Goldstein; J M Thomas; J K Kirklin; J F George
Journal:  Transplantation       Date:  2001-09-15       Impact factor: 4.939

5.  Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice.

Authors:  M Adachi; R Watanabe-Fukunaga; S Nagata
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

6.  A cell population in nu/nu spleen can prevent generation of cytotoxic lymphocytes by normal spleen cells against self antigens of the nu/nu spleen.

Authors:  R G Miller; H Derry
Journal:  J Immunol       Date:  1979-04       Impact factor: 5.422

7.  Peripheral deletion of mature CD8+ antigen-specific T cells after in vivo exposure to male antigen.

Authors:  L I Zhang; D R Martin; W P Fung-Leung; H S Teh; R G Miller
Journal:  J Immunol       Date:  1992-06-15       Impact factor: 5.422

8.  Kidney allograft tolerance in primates without chronic immunosuppression--the role of veto cells.

Authors:  J M Thomas; F M Carver; P R Cunningham; L C Olson; F T Thomas
Journal:  Transplantation       Date:  1991-01       Impact factor: 4.939

9.  Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease.

Authors:  D Zeng; D Lewis; S Dejbakhsh-Jones; F Lan; M García-Ojeda; R Sibley; S Strober
Journal:  J Exp Med       Date:  1999-04-05       Impact factor: 14.307

10.  CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site.

Authors:  K H Sonoda; M Exley; S Snapper; S P Balk; J Stein-Streilein
Journal:  J Exp Med       Date:  1999-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.